The relationship between technetium-99m-methoxyisobutyl isonitrile parathyroid scintigraphy and hormonal and biochemical markers in suspicion of primary hyperparathyroidism
- PMID: 23610725
- PMCID: PMC3629790
- DOI: 10.4274/Mirt.21931
The relationship between technetium-99m-methoxyisobutyl isonitrile parathyroid scintigraphy and hormonal and biochemical markers in suspicion of primary hyperparathyroidism
Abstract
Objective: Technetium-99m-methoxyisobutyl isonitrile (Tc-99m MIBI) has been widely used to evaluate hyperfunctioning autonomous parathyroid glands in patients with elevated intact parathyroid hormone (iPTH) and/or calcium (Ca) level. The aim of this study was to evaluate the relationship between Tc-99m MIBI parathyroid scintigraphy and hormonal and biochemical markers in suspicion of primary hyperparathyroidism (PHPT).
Material and methods: Dual-phase Tc-99m MIBI parathyroid scintigraphy and total serum iPTH, Ca, phosphorus (P) and albumin measurements were performed in 60 patients (52 females, 8 males; mean age, 59.38±12.51 years; range, 34 to 86 years) with suspicion of PHPT.
Results: The iPTH median level was 160.3 pg/mL (47.8 to 782.6). Thirty-five of the patients had surgical resection of hyperfunctioning parathyroid glands. Of the 35 patients, parathyroid gland pathology was detected in 30 patients using scintigraphic examination. Tc-99m MIBI parathyroid scintigraphy was negative in 30 patients. The iPTH, Ca and P levels were significantly different between in the Tc-99m MIBI positive group and the negative group, respectively: For iPTH, 202.1 (47.8-782.6) pg/mL versus 111.6 (80.1-373) pg/mL; p<0.001. For Ca, 11.7±1.15 mg/dL versus 10.3±1.05 mg/dL; p<0.001 and for P levels, 2.46±0.62 mg/dL versus 3.40±0.70 mg/dL; p<0.001). There was no significant difference in serum albumin levels between the MIBI positive and MIBI negative groups (4.25±0.27 g/dL versus 4.25±0.41 g/dL; p>0.05). Tc-99m MIBI parathyroid scintigraphy showed good correlation with iPTH level and histopathological diagnosis. Sensitivity and specificity was found 83.3% and 76.7%, respectively at the level of iPTH>147.7pg/mL.
Conclusion: Tc-99m MIBI parathyroid scintigraphy is most likely to produce identification and localization of a parathyroid adenoma when both iPTH and Ca are elevated as well as decreased P levels.
Conflict of interest: None declared.
Keywords: Technetium-99m sestamibi; calcium; parathyroid hormone; phosphorus; primary hyperparathyroidism.
Figures
Similar articles
-
Positive 99mTc-MIBI and the subtraction parathyroid scan are related to intact parathyroid hormone but not to total plasma calcium in primary hyperparathyroidism.Hell J Nucl Med. 2017 Jan-Apr;20(1):46-50. doi: 10.1967/s002449910506. Epub 2017 Mar 20. Hell J Nucl Med. 2017. PMID: 28315908
-
Tc-99m MIBI parathyroid scintigraphy and intact parathyroid hormone levels in hyperparathyroidism.Clin Nucl Med. 2003 Mar;28(3):180-5. doi: 10.1097/01.RLU.0000053529.71776.37. Clin Nucl Med. 2003. PMID: 12592123
-
Preoperative evaluation of hyperparathyroidism: the role of dual-phase parathyroid scintigraphy and ultrasound imaging.Ann Nucl Med. 2008 Feb;22(2):123-31. doi: 10.1007/s12149-007-0086-z. Epub 2008 Mar 3. Ann Nucl Med. 2008. PMID: 18311537
-
Diagnostic value of clinical parameters and parathyroid scintigraphy for asymptomatic primary hyperparathyroidism.Hell J Nucl Med. 2020 May-Aug;23(2):148-157. doi: 10.1967/s002449912104. Epub 2020 Jul 27. Hell J Nucl Med. 2020. PMID: 32716406
-
Parathyroid nuclear scan. A focused review on the technical and biological factors affecting its outcome.Clin Cases Miner Bone Metab. 2014 Jan;11(1):25-30. Clin Cases Miner Bone Metab. 2014. PMID: 25002876 Free PMC article. Review.
Cited by
-
INTERRELATION BETWEEN PREOPERATIVE TESTS, INTRAOPERATIVE FINDINGS AND OUTCOMES OF 99M-TECHNETIUM-SESTAMIBI SCAN IN PRIMARY HYPERPARATHYROIDISM.Acta Endocrinol (Buchar). 2023 Apr-Jun;19(2):208-214. doi: 10.4183/aeb.2023.208. Epub 2023 Oct 27. Acta Endocrinol (Buchar). 2023. PMID: 37908877 Free PMC article.
-
Doughnut Shaped Parathyroid Adenoma.Mol Imaging Radionucl Ther. 2019 Mar 19;28(1):41-43. doi: 10.4274/mirt.galenos.2018.06977. Mol Imaging Radionucl Ther. 2019. PMID: 30942063 Free PMC article.
-
Correlation between biochemical features and outcomes of preoperative imaging (SPECT-CT and Ultrasound) in primary hyperparathyroidism.Acta Endocrinol (Buchar). 2021 Jul-Sep;17(3):323-330. doi: 10.4183/aeb.2021.323. Acta Endocrinol (Buchar). 2021. PMID: 35342467 Free PMC article.
-
The Relationship between Planar and SPECT/CT Parameters and Functional Markers in Primary Hyperparathyroidism.Diagnostics (Basel). 2023 Oct 11;13(20):3182. doi: 10.3390/diagnostics13203182. Diagnostics (Basel). 2023. PMID: 37892003 Free PMC article.
References
-
- Palestro CJ, Tomas MB, Tronco GG. Radionuclide Imaging of the parathyroid glands. Sem in Nucl Med. 2005;35:266–276. - PubMed
-
- Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med. 1999;341:1249–1255. - PubMed
-
- Yu N, Donnan PT, Leese GP. A record linkage study of outcomes in patients with mild primary hyperparathyroidism: the Parathyroid Epidemiology and Audit Research Study (PEARS) Clin Endocrinol (Oxf) 2011;75:169–176. - PubMed
-
- Bollerslev J, Jansson S, Mollerup CL, Nordenstrom J, Lundgren E, Torring O, Varhaug JE, Baranowski M, Aanderud S, Franco C, Freyschuss B, Isaksen GA, Ueland T, Rosen T. Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. J Clin Endocrinol Metab. 2007;92:1687–1692. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials